[Persistent inflammation immunosuppression catabolism syndrome: a special type of chronic critical illness]
- PMID: 27452746
[Persistent inflammation immunosuppression catabolism syndrome: a special type of chronic critical illness]
Abstract
After the concept of "chronic critical illness (CCI)" was proposed, the new concept persistent inflammation immunosuppression catabolism syndrome (PICS) is present recently. Patients with PICS are manifested by fast decreasing body weight, poor nutritional status, long-term immunosuppression and repeated nosocomial infections. These patients are faced with great challenges of persistent inflammation, acquired immunosuppression and high catabolism, which finally results in repeated nosocomial infections, prolonged hospital stay and increased mortality. At present, main problems of PICS diagnosis standard include varying length of ICU stay, difference in normal C reactive protein value, poor value of nutrition indexes, absence of clinical verification. Though associated pathophysiology mechanism is not clear, PICS is preventable and magageable with certain therapy, including early comprehensive prevention and treatment focused on infection control for CCI patients to stop the progression of PICS, application of immune modulator to improve immune function and prognosis of patients, and reasonable nutritional support and treatment. Besides, through the analysis of the association between PICS and CCI, authors draw a conclusion that PICS is a new phenotype of CCI, and immune paralysis is its main feature.
Similar articles
-
Chronic Critical Illness: Application of What We Know.Nutr Clin Pract. 2018 Feb;33(1):39-45. doi: 10.1002/ncp.10024. Epub 2018 Jan 11. Nutr Clin Pract. 2018. PMID: 29323761 Free PMC article. Review.
-
Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy.Front Immunol. 2018 Apr 4;9:595. doi: 10.3389/fimmu.2018.00595. eCollection 2018. Front Immunol. 2018. PMID: 29670613 Free PMC article. Review.
-
CLINICAL AND PROGNOSTIC FEATURES OF CHRONIC CRITICAL ILLNESS/PERSISTENT INFLAMMATION IMMUNOSUPPRESSION AND CATABOLISM PATIENTS: A PROSPECTIVE OBSERVATIONAL CLINICAL STUDY.Shock. 2023 Jan 1;59(1):5-11. doi: 10.1097/SHK.0000000000002035. Epub 2022 Nov 17. Shock. 2023. PMID: 36383370
-
[Preliminary discussion of therapeutic strategies in persistent inflammation immunosuppression catabolism syndrome].Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Dec 25;20(12):1444-1447. Zhonghua Wei Chang Wai Ke Za Zhi. 2017. PMID: 29280129 Chinese.
-
[A retrospective clinical study of sixty-three cases with persistent inflammation immunosuppression and catabolism syndrome].Zhonghua Nei Ke Za Zhi. 2016 Dec 1;55(12):941-944. doi: 10.3760/cma.j.issn.0578-1426.2016.12.007. Zhonghua Nei Ke Za Zhi. 2016. PMID: 27916049 Chinese.
Cited by
-
Development and validation of a nomogram for predicting persistent inflammation, immunosuppression, and catabolism syndrome in trauma patients.Front Med (Lausanne). 2023 Aug 24;10:1249724. doi: 10.3389/fmed.2023.1249724. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37692780 Free PMC article.
-
Paeonol attenuates inflammation by targeting HMGB1 through upregulating miR-339-5p.Sci Rep. 2019 Dec 18;9(1):19370. doi: 10.1038/s41598-019-55980-4. Sci Rep. 2019. PMID: 31852965 Free PMC article.
-
Clinical treatment for persistent inflammation, immunosuppression and catabolism syndrome in patients with severe acute pancreatitis (Review).Exp Ther Med. 2023 Sep 6;26(4):495. doi: 10.3892/etm.2023.12194. eCollection 2023 Oct. Exp Ther Med. 2023. PMID: 37753297 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials